Gillette India Ltd. Q3 FY25 Financial Overview & Technicals
60
Daily Chart Outlook
1. Short-Term Bias
The stock is caught between a major support cluster (7,245–7,500) and the lower Fair Value Gap near 8,434–8,500.
If bulls can reclaim 8,434 decisively on a daily closing basis, it suggests a push toward the upper FVG (9,045–9,244).
2. Bearish or Bullish Triggers
Bearish: A failure to hold above 8,432–8,434 (0.618 Fib) or repeated rejection in the 8,500 zone could lead to a pullback toward 8,195 or even the mid-7,000s. A daily close below 7,499.95 would reinforce downside momentum.
Bullish: A strong break above 8,500 and especially above 9,045–9,244 (upper FVG) would open the path to test 9,467 (1.618 extension) and potentially higher levels (9,509.50 / 9,825.65).
Watching the FVGs Fair Value Gaps often serve as supply zones. If price enters these zones but struggles to close above them on the daily timeframe, it indicates active sellers. Conversely, a convincing daily close through these FVGs can trigger the next leg up
Fundamentals
Q3 FY25 Financial Highlights:
Net Profit: ₹125.97 crore, a 21% increase from ₹103.95 crore in the same period last year.
Revenue from Operations: ₹685.55 crore, up 7.3% year-on-year from ₹639.46 crore.
Grooming Segment: Revenue rose 11% to ₹570.64 crore; however, EBIT decreased to ₹123.49 crore from ₹129.04 crore.
Oral Care Segment: Revenue declined by 8.25% to ₹114.91 crore, while EBIT increased significantly to ₹38.74 crore from ₹6.49 crore
Dividend Announcement:
Interim Dividend: ₹65 per share for FY25.
Record Date: February 19, 2025; shareholders registered by this date are eligible.
Payment Date: On or before March 7, 2025.
Disclaimer: This analysis is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to risks, and past performance does not guarantee future results. Please conduct your own research or consult a financial advisor before making any investment decisions.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.